{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"thyroid-hurthle-cell-carcinoma","columns":[{"gene":"","key":"population-0ba06dce316def22e933","label":"thyroid Hurthle cell carcinoma","mondoId":"MONDO:0011836","onsetQualifier":null,"originColumnKey":"MONDO:0011836/no-native-evidence","originalViews":[{"key":"MONDO:0011836/no-native-evidence","label":"thyroid Hurthle cell carcinoma","scopeLabel":"No safely mapped HPO entry","sourceScope":"MONDO establishes family membership. No separately scoped phenotype population is safely linked here; parent and sibling values are not copied."}],"recordKeys":[],"recordQualifiers":{},"scopeLabel":"No safely mapped HPO entry","sourceIds":[],"sourceScope":"MONDO establishes family membership. No separately scoped phenotype population is safely linked here; parent and sibling values are not copied."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-0ba06dce316def22e933"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":["population-0ba06dce316def22e933"],"hpoRelease":"not available","narrativeSourceChanges":[],"records":0,"sourceGroups":{}},"features":[],"ledeHtml":"Hurthle cell carcinoma of the thyroid accounts for approximately 3% of all thyroid cancers. Although they are classified as variants of follicular neoplasms, they are more often multifocal and somewhat more aggressive and are less likely to take up iodine than are other follicular neoplasms. Hurthle cell tumors, also known as oxyphil cell tumors, are composed of cells with increased numbers of mitochondria, which corresponds morphologically to their voluminous, granular, eosinophilic cytoplasm.","mondoId":"MONDO:0011836","node":{"canonicalSlug":"thyroid-hurthle-cell-carcinoma","comparisons":[{"documentSha256":"866dec3b944e19fd9ee6f5f7499ee18495fe9c6bd2db4ec84e445cb237d228e1","key":"expanded-thyroid-tumor","kind":"expanded","label":"thyroid tumor","memberIds":["MONDO:0002821","MONDO:0003027","MONDO:0003028","MONDO:0003701","MONDO:0003806","MONDO:0003836","MONDO:0003837","MONDO:0004101","MONDO:0004102","MONDO:0004103","MONDO:0004460","MONDO:0004483","MONDO:0004524","MONDO:0004558","MONDO:0005032","MONDO:0005034","MONDO:0005075","MONDO:0006107","MONDO:0006462","MONDO:0006463","MONDO:0006466","MONDO:0006467","MONDO:0006468","MONDO:0006886","MONDO:0007958","MONDO:0008082","MONDO:0008234","MONDO:0008565","MONDO:0008566","MONDO:0008567","MONDO:0011312","MONDO:0011368","MONDO:0011578","MONDO:0011653","MONDO:0011836","MONDO:0014681","MONDO:0014682","MONDO:0015074","MONDO:0015075","MONDO:0015277","MONDO:0015447","MONDO:0017895","MONDO:0017896","MONDO:0019003","MONDO:0019611","MONDO:0019962","MONDO:0024622","MONDO:0971033","MONDO:0971034","MONDO:0971035","MONDO:0971036"],"mondoId":"MONDO:0015074","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-866dec3b944e19fd9ee6.866dec3b944e19fd9ee6f5f7499ee18495fe9c6bd2db4ec84e445cb237d228e1.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Hurthle cell carcinoma of thyroid","originalSourceId":"OMIM:607464","paragraphs":["Hurthle cell carcinoma of the thyroid accounts for approximately 3% of all thyroid cancers. Although they are classified as variants of follicular neoplasms, they are more often multifocal and somewhat more aggressive and are less likely to take up iodine than are other follicular neoplasms. Hurthle cell tumors, also known as oxyphil cell tumors, are composed of cells with increased numbers of mitochondria, which corresponds morphologically to their voluminous, granular, eosinophilic cytoplasm."],"rawAttribution":"OMIM:607464","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:40:33Z","upstream":"OMIM:607464","url":"https://rarediseases.info.nih.gov/diseases/9428"},"ownColumnKeys":["population-0ba06dce316def22e933"],"publication":"published","relationships":[{"kind":"parent","label":"hereditary disease","mondoId":"MONDO:0003847","slug":null},{"kind":"parent","label":"thyroid gland follicular carcinoma","mondoId":"MONDO:0005034","slug":"thyroid-gland-follicular-carcinoma"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/9428\" rel=\"noreferrer\">GARD</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>OMIM:607464</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Hurthle cell carcinoma of the thyroid accounts for approximately 3% of all thyroid cancers. Although they are classified as variants of follicular neoplasms, they are more often multifocal and somewhat more aggressive and are less likely to take up iodine than are other follicular neoplasms. Hurthle cell tumors, also known as oxyphil cell tumors, are composed of cells with increased numbers of mitochondria, which corresponds morphologically to their voluminous, granular, eosinophilic cytoplasm.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/9428\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"thyroid-hurthle-cell-carcinoma","sourceDocuments":[{"name":"GARD: Hurthle cell carcinoma of thyroid","reviewed":null,"source_release":"2026-10-25T03:40:33Z","url":"https://rarediseases.info.nih.gov/diseases/9428"}],"sourceNote":"","synonyms":["follicular thyroid cancer, Hurthle cell type","Hurthle cell carcinoma of the thyroid","Hurthle cell carcinoma of the thyroid gland","Hurthle cell carcinoma of thyroid","Hurthle cell carcinoma of thyroid gland","Hurthle cell thyroid cancer","Hurthle cell thyroid gland carcinoma","oncocytic carcinoma of the thyroid","oncocytic carcinoma of thyroid","thyroid cancer, follicular, Hurthle cell type","thyroid cancer, Hurthle cell","thyroid carcinoma, Hurthle cell","thyroid gland Hurthle cell carcinoma","thyroid gland oncocytic follicular carcinoma","thyroid Hurthle cell carcinoma","thyroid oncocytic carcinoma"],"takeawayHtml":"","title":"thyroid Hurthle cell carcinoma"},"schemaVersion":1}
